Figure 1: (a) Cell and gene therapy development pathway from patient/donor (red) to recipient (blue); (b) subcellular molecules and ions important for effective cell and gene therapy cultures ...

Cell-based chimeric antigen receptor (CAR) T cell therapies have rapidly advanced in recent years, with a variety of targets in clinical research and several FDA approved products already on the ...

Cell and gene therapies have reached clinical and commercial success as evidenced by the steady number of first approvals over the past four years. Drug developers face mounting challenges linked to ...

This whitepaper introduces CEVEC’s CAP®Ad platform, the ideal technology for scalable, high-productivity and RCA-free Adenoviral vector production.

Be the catalyst for change and experience the future of bioprocessing. Slash biologics development costs, supercharge your pipeline, and deliver transformative therapies with precision, quality, and ...

Explore the latest news and expert commentary on Cell Culture Media, brought to you by the editors of BioProcess International ...

Explore the latest news and expert commentary on Upstream & Downstream Processing, brought to you by the editors of BioProcess International ...

Zuwei Jin, VP of Business Development at LISURE explains the advantages of the M++ system at BioProcess International US West 2025 in San Diego, CA. M++ is a pilot-scale modular benchtop system that ...

When evaluating a new process for viral vector manufacturing, you may be wondering what the best path forward is to save time and resources while ensuring to produce enough data to support the ...

Explore the latest news and expert commentary on Separation/Purification, brought to you by the editors of BioProcess International ...

This webcast features: Andrew Hanneman, Scientific Advisor, Charles River Laboratories One of the major challenges to developing successful biopharmaceutical products is understanding and ...

Isolere Bio is on a mission to transform biomanufacturing and tackle the traditional limitations in downstream processing with its novel IsoTag reagents. This first-of-its-kind technology is based on ...